Flexible Endoscopes Market Size, Share, Growth and Forecast, 2025-2035

Cancer screening and scope replacement lift endoscope sales

The flexible endoscopes market was valued at USD 5.12 billion in 2025 and is projected to increase from USD 5.40 billion in 2026 to USD 8.84 billion by 2035, registering a CAGR of 5.61% during 2025–2035. Demand comes from colorectal and gastric cancer screening, aging populations that need more diagnostic and therapeutic endoscopy, infection-control pressure on reusable scopes and imaging upgrades that pull scope replacement. North America held the largest regional share, 36.0% in 2025, supported by high colonoscopy volumes and early use of single-use bronchoscopes and duodenoscopes. Asia Pacific is the fastest-growing region at 7.40% a year as China adds endoscopy rooms in county hospitals and India expands private GI centers. The main regulatory change came in June 2025, when the U.S. Food and Drug Administration told providers about import alerts on certain Olympus scopes made in Japan, leaving U.S. hospitals to plan fleets around the affected models.

How do hospitals buy flexible endoscopes?

Hospitals and clinics buy most flexible endoscopes as part of a platform. A video processor and light source set the generation, and compatible gastroscopes, colonoscopes, duodenoscopes, bronchoscopes, cystoscopes and ureteroscopes follow. Each procedure room needs a working set of scopes plus spares to cover repair downtime, so growth in procedures turns into fleet purchases, and a new processor generation starts a replacement cycle. Single-use scopes are bought per case instead, which moves part of the spending from capital budgets to consumables.

The estimate counts reusable video endoscopes, single-use flexible endoscopes and fiber-optic endoscopes, which remain in use for ENT, intubation and low-cost settings. It excludes video processors, light sources, monitors and endoscopy towers, capsule endoscopes, endotherapy accessories such as snares, clips and biopsy forceps, and repair contracts and reprocessing equipment, as well as rigid scopes.

Reusable scopes lead while single-use and urology grow

Reusable video scopes lead by type while single-use scopes grow fastest

Based on type, the market is categorized into reusable video endoscopes, single-use flexible endoscopes and fiber-optic endoscopes. Reusable video endoscopes led with 80.0% of 2025 value, because high-volume GI units run each gastroscope and colonoscope through thousands of procedures, keeping cost per case low. Single-use flexible endoscopes grow fastest at 11.82% a year as contamination concerns push hospitals toward disposable bronchoscopes, duodenoscopes and ureteroscopes, which favors makers with dedicated single-use lines. Fiber-optic scopes, meanwhile, keep giving way to video scopes in most settings.

Gastrointestinal endoscopy leads applications while urology grows fastest

Based on application, the market is categorized into gastrointestinal endoscopy, bronchoscopy, urology, ENT and gynecology and other uses. Gastrointestinal endoscopy led with 62.0% of 2025 value, anchored in colonoscopy and gastroscopy for colorectal and stomach cancer detection. Urology grows fastest at 7.60% a year as flexible ureteroscopy replaces open and rigid approaches for kidney stones, a shift that also lifts single-use ureteroscopes and suppliers with strong urology portfolios.

Screening, aging and infection control expand scope fleets

Colorectal and stomach cancer screening keeps GI units busy

Colonoscopy and gastroscopy are the main tools for finding colorectal and stomach cancer early. Estimates published by the World Health Organization's cancer agency rank colorectal cancer third and stomach cancer fifth by new cases worldwide in 2022, at 1.9 million and 970,000 cases. National bowel screening programs in Europe and gastric screening in Japan and South Korea keep procedure rooms full, which sustains replacement demand for gastroscopes and colonoscopes across the full forecast to 2035.

Older patients and lung nodule workups add procedures

Older patients need more diagnostic and therapeutic endoscopy, since bleeding, polyps, bile duct stones, swallowing problems, lung nodules and kidney stones all become more common with age. Lung cancer was the most common cancer in 2022, with 2.5 million new cases, and bronchoscopy is central to diagnosing and staging it. Each new procedure room needs a working set of scopes and spares, so procedure growth in aging markets such as Japan, Europe and North America becomes fleet demand through the 2030s, with bronchoscopy growing faster than GI endoscopy.

Download Free Sample

Contamination cases push hospitals toward single-use scopes

Duodenoscope and bronchoscope contamination cases pushed hospitals toward disposable components and single-use scopes, especially in ERCP and bronchoscopy, where long, narrow channels are hard to clean. Ambu's 2024/25 annual report, released on Nov. 5, 2025, showed its endoscopy business growing faster than the group as a whole, a sign of steady uptake. The effect is strongest in North America and Europe over the next five years.

New 4K processor generations pull scope replacement

A new processor generation usually needs compatible scopes, so platform launches set the replacement cycle in GI and bronchoscopy units. On April 30, 2026, Fujifilm announced that it would show its recently launched ELUXEO 8000 Endoscopic Imaging System, a single-unit processor and light source with 4K imaging and a new Amber-Red Color Imaging mode, together with 800 Series upper endoscopes and colonoscopes, at Digestive Disease Week 2026 in Chicago. Hospitals that move to such platforms refresh scope fleets over the medium term, because processors and scopes must match.

Disposable scopes spread as 4K imaging resets replacement

Single-use scopes shift into urology, ERCP and gastroscopy

Single-use scopes started in bronchoscopy and intubation and are now used in urology, ERCP and gastroscopy. Ambu, Boston Scientific, Olympus, Karl Storz and OTU Medical all sell disposable scopes. The shift turns part of scope spending into a per-procedure consumable and favors suppliers that can lower unit cost while keeping image quality acceptable. Reusable makers answer with their own disposable lines, so the trend widens competition rather than removing incumbents from the procedures they already serve.

The rise of 4K, multi-light imaging and computer-aided detection

Scope makers are launching 4K processors with new light modes and computer-aided detection of polyps and lesions. Each generation competes on resolution, light modes and software assistance, and because processors and scopes must match, every step lifts scope replacement in GI units first and bronchoscopy next. Software that flags lesions during a procedure also raises the value of whole platforms rather than single scopes, which helps incumbents.

Download Free Sample

Urology and bronchoscopy outgrow GI endoscopy as a growth opportunity

Urology is the fastest-growing application at 7.60% a year, as flexible ureteroscopy replaces open and rigid approaches for kidney stones, and bronchoscopy also grows faster than GI endoscopy as lung nodule workups expand. Suppliers with ureteroscopes, cystoscopes and bronchoscopes, both reusable and single-use, can win share in these smaller but faster pools. The opening is largest in North America and Europe, where stone treatment and lung cancer workups are routine.

First-time fleet purchases across Asia Pacific open an opportunity

Asia Pacific is the fastest-growing region, with much of its demand coming from first-time fleet buyers in Chinese county hospitals and Indian private GI centers. Chinese makers such as SonoScape and Aohua win public tenders at home and export lower-priced video scopes to emerging markets. Suppliers that offer complete, affordable platforms with training and local service can capture these first-time purchases rather than replacement orders alone.

Reprocessing risk and repair bills hold spending back

Hard-to-clean channels make reprocessing a liability

Reusable flexible scopes have long, narrow channels that are hard to clean, and contamination cases lead to recalls, lawsuits and tighter rules. Hospitals and endoscopy units carry the cost through extra cleaning steps, testing and staff time, which raises the cost of each procedure and can take scopes out of service. Mitigation comes from better cleaning equipment, from disposable components on high-risk scopes and from selective use of single-use models in ERCP and bronchoscopy.

Repair bills and tight budgets stretch scope life

Flexible scopes are damaged often, and repair and loaner programs form a large part of their lifetime cost. When budgets tighten, hospitals and public tenders stretch scope life rather than buy new fleets, which delays replacement and slows unit sales, most visibly in Europe, where the market grows at 4.30% a year. Suppliers respond with service contracts, faster repair turnaround and loaner pools that keep buyers on their platforms through the next processor generation.

Per-case cost and plastic waste limit single-use adoption

Single-use scopes cost more per case than reusable scopes in high-volume GI units, and each one adds plastic waste. Hospital purchasing committees therefore restrict them to selected procedures, which caps adoption in gastroscopy and colonoscopy, the largest application. The commercial result is slower single-use growth in the biggest pool of procedures. Makers address the barrier by cutting unit prices and targeting high-risk cases such as ERCP and bronchoscopy, where avoided infections and faster room turnover justify the premium.

Concentrated supply turns a plant problem into a category shortage

A few makers supply most reusable scopes, so a quality problem at one plant can tighten supply for a whole category. In a June 24, 2025, letter, the U.S. Food and Drug Administration told providers about import alerts on certain Olympus bronchoscopes, ureterorenoscopes and reprocessors from its Aizu site in Japan, citing quality system violations. Providers could keep using working devices, but U.S. hospitals had to plan fleets around the affected models. For hospitals, second suppliers and single-use backups reduce the exposure.

North America buys the most scopes as Asia adds rooms

North America combines high colonoscopy volumes with early single-use uptake

North America held 36.0% of 2025 value and grows at 4.80% a year. The United States accounts for most of it, with high colonoscopy volumes, routine bronchoscopy for lung nodules and early adoption of single-use bronchoscopes and duodenoscopes, which keep spending per procedure high. The June 2025 FDA import alert on certain Olympus models made in Japan left U.S. hospitals planning scope fleets around those models, while Fujifilm, Pentax Medical, Karl Storz and single-use makers compete for replacement orders.

Asia Pacific grows on gastric screening, county hospitals and private GI centers

Asia Pacific held 30.0% of 2025 value and is the fastest-growing region at 7.40% a year. Japan and South Korea run large gastric cancer screening programs, and the region is home to Olympus, Fujifilm and Pentax Medical, the three makers that supply most reusable scopes. China is adding endoscopy rooms in county hospitals, where SonoScape and Aohua win public tenders with lower-priced video scopes, and India is expanding private GI centers. First-time fleet purchases make the region the main source of new unit demand.

Download Free Sample

Europe pairs bowel screening volumes with long replacement cycles

Europe held 27.0% of 2025 value and grows at 4.30% a year, the slowest of the five regions. National bowel cancer screening programs keep colonoscopy volumes high, but public tenders and tight hospital budgets stretch scope life and favor long replacement cycles. Karl Storz and Richard Wolf compete strongly in ENT and urology scopes. Single-use uptake is selective, shaped by cost and plastic-waste concerns, so growth relies on platform upgrades and on urology and bronchoscopy procedures.

Latin America and Middle East & Africa rely on private hospitals and Gulf projects

Latin America held 4.0% of 2025 value and grows at 6.00% a year, as screening programs and private hospital groups add endoscopy rooms. The Middle East & Africa held 3.0% and grows at 6.50% a year, led by Gulf hospital projects. Both regions buy mostly mid-priced video platforms and are open to lower-cost scopes from Asian makers.

Download Free Sample

An FDA import alert and a 4K platform mark 2024–2026

Imaging, single-use design and reprocessing shape buying

• Imaging advances such as 4K processors, new light modes like Fujifilm's Amber-Red Color Imaging and computer-aided detection of polyps raise detection and pull scope upgrades.
• Single-use design in disposable bronchoscopes, ureteroscopes and duodenoscopes removes reprocessing from high-risk procedures, with unit cost and plastic waste as the limits.
• Reprocessing improvements such as disposable components, better cleaning equipment and leak testing lower contamination risk across reusable fleets.
• Navigation through robotic and navigation bronchoscopy extends flexible scopes to peripheral lung nodules and adds procedures.
• Regulation through FDA quality-system enforcement, including the 2025 Olympus import alerts, makes manufacturing compliance a supply factor.

Japanese platform makers face single-use and Chinese rivals

Competition splits into three groups, and the first is made up of Olympus, Fujifilm and Pentax Medical (HOYA), the three Japanese makers that supply most reusable scopes and sell full processor and scope platforms. Olympus is the clear leader in GI endoscopy, and its 2026 company profile shows Gastrointestinal Solutions as the larger of its two divisions in the year to March 2026. Karl Storz is strong in ENT, urology and intubation scopes, and Richard Wolf in urology. Single-use specialists led by Ambu, with Boston Scientific and OTU Medical, compete on infection risk and room turnover. SonoScape and Aohua compete on price in Chinese tenders and emerging markets. Buyers compare whole platforms, including repair turnaround and loaner scopes, which keeps incumbents in most replacement orders. No company reports flexible scope sales on a comparable basis, so no share ranking is given.

Companies profiled and their roles

Replacement sets the base while single-use sets the pace

Credence Research's view is that flexible endoscopy remains a replacement-led market built on gastroscopes and colonoscopes, with value growth coming from single-use scopes in bronchoscopy, urology and ERCP and from 4K platforms that pull scope upgrades. The three Japanese makers will keep most GI demand, where installed processors lock in buyers, while single-use specialists and Chinese makers take share in faster pools. The main risk is supply disruption from quality enforcement at concentrated plants. Buyers and investors should watch FDA actions, single-use pricing and Chinese tender results.

How Credence Research sized flexible scope sales

The report uses 2025 as the base year and forecasts to 2035, with CAGR calculated over 2025–2035. Market values come from Credence Research's market model, built from endoscopy procedure volumes, installed scope fleets and replacement cycles and checked against the endoscopy segment disclosures of listed scope makers; segment and regional splits are Credence Research estimates. Supporting evidence comes from WHO cancer statistics, FDA notices, company annual reports and company announcements.

GI fleets anchor demand while urology and bronchoscopy grow

Through 2035, GI endoscopy will remain the core of demand, supported by cancer screening and aging populations, while urology and bronchoscopy grow faster. Single-use scopes will move further into ERCP, urology and selected gastroscopy, but cost and waste will keep reusable scopes dominant in high-volume units. Asia Pacific will gain share as China and India add procedure rooms, and North America will remain the largest region. Imaging generations with 4K and computer-aided detection will set replacement timing, and manufacturing quality will matter as much as image quality for supply.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.